Clinical evaluation of high mobility group box 1 protein in Legionella pneumophila pneumonia

J Infect Chemother. 2014 May;20(5):289-92. doi: 10.1016/j.jiac.2013.10.014. Epub 2013 Dec 11.

Abstract

High mobility group box 1 (HMGB-1) protein is involved in acute lung injury due to various etiologies. We evaluated HMGB-1 levels in sera and bronchoalveolar fluids in patients with pneumonia caused by Legionella pneumophila. Levels of HMGB-1 in the sera of patients with L. pneumophila pneumonia (32 cases) and control subjects (24 cases) were determined. Serum HMGB-1 levels in Legionella pneumonia were similar to those of the control subjects. No significant correlation between HMGB-1 levels and other biomarkers and the outcome of cases was observed. In contrast, HMGB-1 levels, as well as interferon-γ, in bronchoalveolar (BA) fluids from severe L. pneumophila pneumonia (7 cases) were significantly higher than those in the sera of identical patients. HMGB-1 levels in BA fluids were relatively higher in pneumonia cases with ALI than those without ALI. Our findings suggest that intra-pulmonary HMGB-1 may be involved in the pathophysiology of pneumonia caused by L. pneumophila.

Keywords: Acute lung injury; High-mobility group box 1 protein; Legionella; Pneumonia.

MeSH terms

  • Aged
  • Bronchoalveolar Lavage Fluid / chemistry
  • Female
  • HMGB1 Protein / analysis
  • HMGB1 Protein / physiology*
  • Hepatocyte Growth Factor / physiology
  • Humans
  • Interferon-gamma / physiology
  • Legionnaires' Disease / etiology*
  • Male
  • Middle Aged

Substances

  • HMGB1 Protein
  • Hepatocyte Growth Factor
  • Interferon-gamma